Ligands for peroxisome proliferator-activated receptor gamma have potent antitumor effect against human renal cell carcinoma

Ligands for PPARγ have multiple antitumor effects in human RCC cells in vitro. Activation of the PPARγ pathway may be a new strategy for treatment of patients with RCC.